Live feed06:30:00·1471dPRReleasevia QuantisnowImmunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis and Provides Corporate UpdateByQuantisnow·Wall Street's wire, on your screen.IMUX· Immunic Inc.Health Care
